CSIMarket
 


Merck and Co Inc   (MRK)
Other Ticker:  
 
 

MRK's EPS from Cont. Operations Growth by Quarter and Year

Merck And Co Inc 's EPS from Cont. Operations results by quarter and year




MRK EPS from Cont. Operations (in $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 0.00 1.19 1.48 -0.83
III Quarter September 1.87 1.28 1.81 1.16
II Quarter June -2.35 1.56 0.48 1.19
I Quarter March 1.11 1.70 1.26 1.27
FY   0.63 5.73 5.03 2.79



MRK EPS from Cont. Operations fourth quarter 2023 Y/Y Growth Comment
Merck and Co Inc in the fourth quarter 2023 recorded EPS loss from Cont. Operations of $ 0.00 .

Looking into fourth quarter 2023 results within Major Pharmaceutical Preparations industry 9 other companies have achieved higher EPS from Cont. Operations growth. While Merck And Co Inc ' s EPS from Cont. Operations no change of % ranks overall at the positon no. 747 in the fourth quarter 2023.




MRK EPS from Cont. Operations ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - -19.59 % - -
III Quarter September 46.09 % -29.28 % 56.03 % 56.76 %
II Quarter June - 225 % -59.66 % 14.42 %
I Quarter March -34.71 % 34.92 % -0.79 % 12.39 %
FY   -89.01 % 13.92 % 80.29 % -27.34 %

Financial Statements
Merck And Co Inc 's fourth quarter 2023 EPS from Cont. Operations $ 0.00 MRK's Income Statement
Merck And Co Inc 's fourth quarter 2022 EPS from Cont. Operations $ 1.19 Quarterly MRK's Income Statement
New: More MRK's historic EPS from Cont. Operations Growth >>


MRK EPS from Cont. Operations (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - -7.03 % -18.23 % -
III Quarter September - -17.95 % 277.08 % -2.52 %
II Quarter June - -8.24 % -61.9 % -6.3 %
I Quarter March -6.72 % 14.86 % - 36.56 %
FY (Year on Year)   -89.01 % 13.92 % 80.29 % -27.34 %




EPS from Cont. Operations fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #10
Healthcare Sector #56
Overall #747

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
651.85 % 39.1 % -94.97 %
(Dec 31 2011)   (Dec. 30, 2010)
EPS from Cont. Operations fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #10
Healthcare Sector #56
Overall #747
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
651.85 % 39.1 % -94.97 %
(Dec 31 2011)   (Dec. 30, 2010)

EPS from Cont. Operations by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Merck And Co Inc 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


MRK's IV. Quarter Q/Q EPS from Cont. Operations Comment
Recent accomplishment of 0.00 by Merck and Co Inc appear even more unfavourable compare to the 1.87 EPS loss from Cont. Operations in the previous quarter.

Within Major Pharmaceutical Preparations industry Merck and Co Inc achieved highest sequential EPS from Cont. Operations growth. While Merck And Co Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


MRK's IV. Quarter Q/Q EPS from Cont. Operations Comment
Current EPS loss from Cont. Operations of 0.00 by Merck and Co Inc come out even less good considering the EPS loss from Cont. Operations 1.87 in the previous quarter.

Within Major Pharmaceutical Preparations industry Merck and Co Inc achieved highest sequential EPS from Cont. Operations growth. While Merck And Co Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


Merck And Co Inc 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative EPS from Cont. Operations 12 Months Ending $ 1.82 $ 1.23 $ 5.14 $ 5.73 $ 6.02
Y / Y EPS from Cont. Operations Growth (TTM) -69.77 % -81.22 % -6.05 % 13.89 % 120.98 %
Year on Year EPS from Cont. Operations Growth Overall Ranking # 108 # 81 # 193 # 0 # 261
Seqeuential EPS from Cont. Operations Change (TTM) 47.95 % -76.06 % -10.3 % -4.84 % -8.09 %
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # 747 # 1031 # 1019 # 0 # 254




Cumulative EPS from Cont. Operations growth Comment
Merck And Co Inc showed decline, but improvement compare to trailing twelve month EPS from Cont. Operations decrease in Jun 30 2023. If the fiscal year would end in Sep 30 2023, Merck And Co Inc 's annual EPS from Cont. Operations decrease would be -69.77% year on year to $2 .

Among companies within the Healthcare sector 6 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While EPS from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 81 to 108.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
651.85 %
39.1 %
-94.97 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 10
Healthcare Sector # 7
Overall # 108

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
651.85 %
39.1 %
-94.97 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 56
S&P 500 # 747
Cumulative EPS from Cont. Operations growth Comment
Merck And Co Inc showed decline, but improvement compare to trailing twelve month EPS from Cont. Operations decrease in Jun 30 2023. If the fiscal year would end in Sep 30 2023, Merck And Co Inc 's annual EPS from Cont. Operations drop would be -69.77% year on year to $2 .

Among companies within the Healthcare sector 6 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While EPS from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 81 to 108.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
651.85 %
39.1 %
-94.97 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 10
Healthcare Sector # 7
Overall # 108

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
651.85 %
39.1 %
-94.97 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 56
S&P 500 # 747




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
MRK's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for MRK's Competitors
EPS from Cont. Operations Growth for Merck And Co Inc 's Suppliers
EPS from Cont. Operations Growth for MRK's Customers

You may also want to know
MRK's Annual Growth Rates MRK's Profitability Ratios MRK's Asset Turnover Ratio MRK's Dividend Growth
MRK's Roe MRK's Valuation Ratios MRK's Financial Strength Ratios MRK's Dividend Payout Ratio
MRK's Roa MRK's Inventory Turnover Ratio MRK's Growth Rates MRK's Dividend Comparisons



Companies with similar EPS from Cont. Operations drop for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Dec 31 2023
Charles River Laboratories International inc -0.95%$ -0.946 
Regeneron Pharmaceuticals Inc -2.77%$ -2.768 
Docgo Inc -3.90%$ -3.902 
Haemonetics Corporation-4.62%$ -4.615 
Edwards Lifesciences Corporation-5.96%$ -5.957 
Resmed Inc -7.19%$ -7.190 
Bristol myers Squibb Company-8.40%$ -8.397 
Gilead Sciences Inc -12.83%$ -12.832 
Utah Medical Products Inc-14.12%$ -14.124 
Masimo Corp-17.78%$ -17.782 
Merit Medical Systems Inc-18.28%$ -18.277 
Qiagen N v -19.35%$ -19.355 
Fresenius Medical Care Ag-26.09%$ -26.087 
Mettler toledo International Inc -28.51%$ -28.506 
Avantor Inc -30.61%$ -30.610 
Amedisys Inc -39.32%$ -39.315 
Avanos Medical Inc -39.47%$ -39.469 
Becton Dickinson And Company-43.27%$ -43.275 
Embecta Corp -43.55%$ -43.548 
Pro dex Inc -44.00%$ -44.000 
Harmony Biosciences Holdings inc -44.04%$ -44.044 
Bio techne Corp-46.88%$ -46.875 
Star Equity Holdings Inc -47.42%$ -47.416 
Amgen Inc -52.75%$ -52.746 
Biogen Inc -54.98%$ -54.977 
Taro Pharmaceutical Industries Ltd-56.13%$ -56.129 
Bio rad Laboratories Inc -56.74%$ -56.736 
Integra Lifesciences Holdings Corp-60.46%$ -60.461 
Henry Schein Inc-60.47%$ -60.467 
Teleflex Incorporated-60.61%$ -60.605 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com